Showing 1 - 20 results of 262,913 for search '(((( 12 greater decrease ) OR ( 10 ((_ decrease) OR (a decrease)) ))) OR ( 10 we decrease ))*', query time: 1.89s Refine Results
  1. 1

    Normalized synergy increased with greater recurrence and decreased with greater feedback. by Samantha P. Sherrill (11114128)

    Published 2021
    “…The background heatmap, wherein brighter colors reflect larger normalized synergy values, replots the central tendency of the values shown in <a href="http://www.ploscompbiol.org/article/info:doi/10.1371/journal.pcbi.1009196#pcbi.1009196.g003" target="_blank">Fig 3</a>. …”
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6

    Table_1_Trans ε-Viniferin Decreases Amyloid Deposits With Greater Efficiency Than Resveratrol in an Alzheimer’s Mouse Model.pdf by Aline Freyssin (11912204)

    Published 2022
    “…Then, amyloid burden and neuroinflammation were quantified by western-blot, Enzyme-Linked ImmunoSorbent Assay (ELISA), immunofluorescence, and in vivo micro-Positon Emission Tomography (PET) imaging. Viniferin decreased hippocampal amyloid load and deposits with greater efficiency than resveratrol, and both treatments partially prevented the cognitive decline. …”
  7. 7

    Image_1_Trans ε-Viniferin Decreases Amyloid Deposits With Greater Efficiency Than Resveratrol in an Alzheimer’s Mouse Model.pdf by Aline Freyssin (11912204)

    Published 2022
    “…Then, amyloid burden and neuroinflammation were quantified by western-blot, Enzyme-Linked ImmunoSorbent Assay (ELISA), immunofluorescence, and in vivo micro-Positon Emission Tomography (PET) imaging. Viniferin decreased hippocampal amyloid load and deposits with greater efficiency than resveratrol, and both treatments partially prevented the cognitive decline. …”
  8. 8

    Image_3_Trans ε-Viniferin Decreases Amyloid Deposits With Greater Efficiency Than Resveratrol in an Alzheimer’s Mouse Model.pdf by Aline Freyssin (11912204)

    Published 2022
    “…Then, amyloid burden and neuroinflammation were quantified by western-blot, Enzyme-Linked ImmunoSorbent Assay (ELISA), immunofluorescence, and in vivo micro-Positon Emission Tomography (PET) imaging. Viniferin decreased hippocampal amyloid load and deposits with greater efficiency than resveratrol, and both treatments partially prevented the cognitive decline. …”
  9. 9

    Image_2_Trans ε-Viniferin Decreases Amyloid Deposits With Greater Efficiency Than Resveratrol in an Alzheimer’s Mouse Model.pdf by Aline Freyssin (11912204)

    Published 2022
    “…Then, amyloid burden and neuroinflammation were quantified by western-blot, Enzyme-Linked ImmunoSorbent Assay (ELISA), immunofluorescence, and in vivo micro-Positon Emission Tomography (PET) imaging. Viniferin decreased hippocampal amyloid load and deposits with greater efficiency than resveratrol, and both treatments partially prevented the cognitive decline. …”
  10. 10

    Table_2_Trans ε-Viniferin Decreases Amyloid Deposits With Greater Efficiency Than Resveratrol in an Alzheimer’s Mouse Model.pdf by Aline Freyssin (11912204)

    Published 2022
    “…Then, amyloid burden and neuroinflammation were quantified by western-blot, Enzyme-Linked ImmunoSorbent Assay (ELISA), immunofluorescence, and in vivo micro-Positon Emission Tomography (PET) imaging. Viniferin decreased hippocampal amyloid load and deposits with greater efficiency than resveratrol, and both treatments partially prevented the cognitive decline. …”
  11. 11

    Image_4_Trans ε-Viniferin Decreases Amyloid Deposits With Greater Efficiency Than Resveratrol in an Alzheimer’s Mouse Model.pdf by Aline Freyssin (11912204)

    Published 2022
    “…Then, amyloid burden and neuroinflammation were quantified by western-blot, Enzyme-Linked ImmunoSorbent Assay (ELISA), immunofluorescence, and in vivo micro-Positon Emission Tomography (PET) imaging. Viniferin decreased hippocampal amyloid load and deposits with greater efficiency than resveratrol, and both treatments partially prevented the cognitive decline. …”
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16

    Decreased Patrolling Efficiency and Decreased ConA Hepatitis Severity in CXCR6-Deficient Mice by Frederic Geissmann (75)

    Published 2013
    “…The density of GFP<sup>+</sup> cells in <i>cxcr6<sup>gfp/+</sup></i> and <i>cxcr6<sup>gfp/gfp</sup></i> mice (middle panel) was calculated from the intravital videos used in <a href="http://www.plosbiology.org/article/info:doi/10.1371/journal.pbio.0030113#pbio-0030113-g003" target="_blank">Figure 3</a> and the flow cytometry data in <a href="http://www.plosbiology.org/article/info:doi/10.1371/journal.pbio.0030113#pbio-0030113-g002" target="_blank">Figure 2</a>. …”
  17. 17
  18. 18
  19. 19
  20. 20